Πλοήγηση ανά Συγγραφέα "Plaitakis, A."
-
Assessment of Parkinson's disease risk loci in Greece
Kara, E.; Xiromerisiou, G.; Spanaki, C.; Bozi, M.; Koutsis, G.; Panas, M.; Dardiotis, E.; Ralli, S.; Bras, J.; Letson, C.; Edsall, C.; Pliner, H.; Arepalli, S.; Kalinderi, K.; Fidani, L.; Bostantjopoulou, S.; Keller, M. F.; Wood, N. W.; Hardy, J.; Houlden, H.; Stefanis, L.; Plaitakis, A.; Hernandez, D.; Hadjigeorgiou, G. M.; Nalls, M. A.; Singleton, A. B. (2014)Genome-wide association studies (GWAS) have been shown to be a powerful approach to identify risk loci for neurodegenerative diseases. Recent GWAS in Parkinson's disease (PD) have been successful in identifying numerous ... -
Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset
Plaitakis, A.; Latsoudis, H.; Kanavouras, K.; Ritz, B.; Bronstein, J. M.; Skoula, I.; Mastorodemos, V.; Papapetropoulos, S.; Borompokas, N.; Zaganas, I.; Xiromerisiou, G.; Hadjigeorgiou, G. M.; Spanaki, C. (2010)Parkinson's disease (PD), a common neurodegenerative disorder characterized by progressive loss of dopaminergic neurons and their terminations in the basal ganglia, is thought to be related to genetic and environmental ... -
An open-label, add-on study of pregabalin in patients with partial seizures: A multicenter trial in Greece
Tsounis, S.; Kimiskidis, V. K.; Kazis, D.; Gkiatas, K.; Garganis, K.; Karageorgiou, K.; Giannakodimos, S.; Papathanasopoulos, P.; Plaitakis, A.; Papadimitriou, A.; Lyras, L.; Emir, B. (2011)Introduction: Pregabalin efficacy and safety as an adjunctive treatment for partial seizures was evaluated using an open-label, flexible-dose. Study design: In 98 adults with refractory partial epilepsy taking 1-3 ... -
AN OPEN-LABEL, ADD-ON STUDY OF PREGABALIN IN PATIENTS WITH PARTIAL SEIZURES: A MULTICENTER TRIAL IN GREECE
Tsounis, S.; Kimiskidis, V.; Kazis, D.; Gkiatas, K.; Garganis, K.; Karageorgiou, K.; Giannakodimos, S.; Papathanasopoulos, P.; Plaitakis, A.; Papadimitriou, A.; Donevan, S.; Lyras, L. (2009)